A new study links urinary metabolites from organophosphorus pesticides to increased age-related macular degeneration risk.

AAV204 is a novel adeno-associated virus (AAV) capsid from the AIM capsid library licensed by Abeona from the University of ...

Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...

New technologies and a proactive mindset are transforming how glaucoma is diagnosed and treated—and redefining what ...

RGN-259 is a thymosin beta-4–based eye drop designed to rival Dompé’s Oxervate, the only FDA-approved prescription eye drop ...

Nanoscope Therapeutics formed the Vision Advisory Committee to guide its efforts in retinal care, focusing on retinitis ...

A new study demonstrates that handheld nanopore sequencers can rapidly identify eye infection pathogens using only a ...

In addition to Prevent Blindness’s usual free resources, the organization is providing a dedicated webpage, fact sheets, and ...

Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...

The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...

Yesafili is a VEGF inhibitor indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD), ...

New findings reveal RG6501 cell therapy shows promising long-term visual improvements for geographic atrophy patients ...